Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2012 | 56 | 0.850 |
Why?
|
| Proto-Oncogene Proteins c-myb | 2 | 2012 | 9 | 0.810 |
Why?
|
| Receptors, Glucocorticoid | 3 | 2012 | 135 | 0.530 |
Why?
|
| Chemokines | 1 | 2013 | 74 | 0.440 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 538 | 0.320 |
Why?
|
| Gene Knockdown Techniques | 4 | 2013 | 247 | 0.290 |
Why?
|
| Apoptosis | 4 | 2012 | 1718 | 0.240 |
Why?
|
| Matrix Metalloproteinase 14 | 2 | 2014 | 5 | 0.230 |
Why?
|
| Doxycycline | 3 | 2012 | 29 | 0.220 |
Why?
|
| Brain Neoplasms | 3 | 2014 | 784 | 0.210 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2012 | 93 | 0.180 |
Why?
|
| Cell Line, Tumor | 5 | 2013 | 2588 | 0.180 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2012 | 54 | 0.180 |
Why?
|
| Neoplasm Metastasis | 2 | 2013 | 1066 | 0.160 |
Why?
|
| Neoplasms | 1 | 2013 | 3067 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2014 | 486 | 0.140 |
Why?
|
| Dexamethasone | 3 | 2012 | 343 | 0.130 |
Why?
|
| Genetic Vectors | 2 | 2012 | 446 | 0.110 |
Why?
|
| Radiation | 1 | 2013 | 15 | 0.110 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 557 | 0.110 |
Why?
|
| Genetic Therapy | 2 | 2012 | 372 | 0.110 |
Why?
|
| Dacarbazine | 1 | 2013 | 101 | 0.100 |
Why?
|
| Genes, myb | 1 | 2012 | 5 | 0.100 |
Why?
|
| Branched DNA Signal Amplification Assay | 1 | 2012 | 1 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2012 | 726 | 0.100 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2013 | 135 | 0.100 |
Why?
|
| Lentivirus | 1 | 2012 | 43 | 0.100 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2012 | 27 | 0.100 |
Why?
|
| Carcinogenesis | 1 | 2014 | 216 | 0.100 |
Why?
|
| Mice, Inbred NOD | 1 | 2012 | 198 | 0.100 |
Why?
|
| Mice, SCID | 1 | 2012 | 259 | 0.100 |
Why?
|
| DNA Replication | 1 | 2012 | 171 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2014 | 268 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2012 | 2026 | 0.100 |
Why?
|
| Animals | 5 | 2014 | 27536 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 194 | 0.090 |
Why?
|
| Steroids | 1 | 2012 | 173 | 0.090 |
Why?
|
| MicroRNAs | 2 | 2013 | 556 | 0.090 |
Why?
|
| Glioma | 1 | 2013 | 295 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2013 | 1284 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 885 | 0.090 |
Why?
|
| Mice | 3 | 2013 | 11858 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 450 | 0.080 |
Why?
|
| Disease Progression | 1 | 2013 | 1469 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 961 | 0.080 |
Why?
|
| Protein Binding | 1 | 2012 | 1492 | 0.080 |
Why?
|
| Humans | 8 | 2014 | 89985 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2013 | 3404 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2012 | 606 | 0.040 |
Why?
|
| Brain | 2 | 2014 | 2306 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2013 | 178 | 0.030 |
Why?
|
| Oncolytic Virotherapy | 1 | 2012 | 42 | 0.030 |
Why?
|
| RNA Stability | 1 | 2012 | 90 | 0.020 |
Why?
|
| RNA Interference | 1 | 2013 | 376 | 0.020 |
Why?
|
| Female | 2 | 2013 | 46602 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 280 | 0.020 |
Why?
|
| Cell Division | 1 | 2013 | 692 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2012 | 145 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 983 | 0.020 |
Why?
|
| Exons | 1 | 2012 | 453 | 0.020 |
Why?
|
| Titrimetry | 1 | 2010 | 15 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2010 | 38 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2012 | 357 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2012 | 476 | 0.020 |
Why?
|
| Precision Medicine | 1 | 2012 | 413 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2010 | 508 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1158 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 1670 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 1452 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 2395 | 0.020 |
Why?
|
| Child | 1 | 2012 | 7242 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 9345 | 0.010 |
Why?
|